# The9 LTD: Form 20-F for the period ended Dec 31, 2024

- Company: [The9 LTD](/companies/ncty.md) (CIK 1296774)
- Form: 20-F
- Filed: 2025-04-28
- Accepted by EDGAR: Apr 28, 2025, 16:02 ET
- Period: 2024-12-31
- Accession: 0001410578-25-000945
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1296774/000141057825000945/ncty-20241231x20f.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1296774/000141057825000945/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2024-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2024-01-01 to 2024-12-31 | $15.3m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months, 2024-01-01 to 2024-12-31 | $15.5m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 12 months, 2024-01-01 to 2024-12-31 | −$219.0k | us-gaap:GrossProfit |
| Research and development | 12 months, 2024-01-01 to 2024-12-31 | $117.0k | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months, 2024-01-01 to 2024-12-31 | −$8.1m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months, 2024-01-01 to 2024-12-31 | $4.7m | us-gaap:InterestExpenseNonoperating |
| Income tax | 12 months, 2024-01-01 to 2024-12-31 | $0 | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2024-01-01 to 2024-12-31 | −$10.1m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months, 2024-01-01 to 2024-12-31 | −$0.01 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months, 2024-01-01 to 2024-12-31 | −$0.01 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months, 2024-01-01 to 2024-12-31 | 1,403,166 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2024-01-01 to 2024-12-31 | −$6.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | at 2024-12-31 | $1.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2024-12-31 | $33.4m | us-gaap:AssetsCurrent |
| Total assets | at 2024-12-31 | $87.2m | us-gaap:Assets |
| Current liabilities | at 2024-12-31 | $28.2m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2024-12-31 | $28.7m | us-gaap:Liabilities |
| Short-term borrowings | at 2024-12-31 | $12.2m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2024-12-31 | $46.4m | us-gaap:StockholdersEquity |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1296774/000141057825000945/ncty-20241231x20f.htm

Filed Apr 28, 2025.
Source: SEC EDGAR, the filing index for accession 0001410578-25-000945. Last ingested by Listed: Nov 2, 2026, 06:20 ET. No prices; not investment advice.
